Breast Cancer - Pipeline Review, 2015 is a new market research publication announced by Reportstack. This report provides an overview of Breast Cancer diagnostic tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Breast Cancer diagnostic tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.
To view the table of contents and know more details, please visit Breast Cancer - Pipeline Review, 2015.
- Extensive coverage of the Breast Cancer diagnostic tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Breast Cancer diagnostic tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Breast Cancer diagnostic tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
A&G Pharmaceutical, Inc. Abbott Diagnostics Abcodia Ltd. Abviva, Inc. Accelerated Medical Diagnostics Acobiom Advanced Cell Diagnostics, Inc. Affichem SA AIT Austrian Institute of Technology GmbH Almac Diagnostics Limited Amarantus Bioscience Holdings, Inc. AngioGenex, Inc. Armune BioScience, Inc. Arno Therapeutics, Inc. AroCell AB ArtemixRx Ascendant Diagnostics, LLC Assurance Biosciences, Inc. Atossa Genetics, Inc. Autoimmune Technologies, LLC Ayanda Biosystems S.A. Becton, Dickinson and Company Bio Gene Ltd. BioAffinity Technologies, Inc. Biocrates Life Sciences AG Biodesix Inc. BioMarCare Technologies Ltd. BioMark Diagnostics Inc. BioMark Technologies Inc. BioMarker Strategies, LLC bioMerieux S.A. Biosceptre (Aust) Pty Ltd BioSystems International bioTheranostics, Inc. Boston College Candiag LLC. Caprion Inc. Cellanyx Diagnostics, Inc. CellXplore, Inc. Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Cepheid Ceres Nanosciences, Inc. Cernostics Inc. China Sky One Medical, Inc. Chronix Biomedical, Inc. Clarient, Inc. Cleveland Diagnostics Inc. Clovis Oncology, Inc. CompanDX Ltd. Courtagen Life Sciences, Inc. CS-Keys, Inc. Da An Gene Co., Ltd. Dana-Farber Cancer Institute, Inc. Dartmouth College diaDexus, Inc. Diaxonhit S.A. Dublin City University Eventus Diagnostics, Inc. Exiqon A/S Exosomics Siena SpA Fermiscan Holdings Limited Fina Biotech Fluxion Biosciences, Inc. Fournira Optime Diagnostics GeneAssess, Inc. GeneFluidics Inc. GeneNews Limited GenomicTree, Inc. George Washington University German Cancer Research Center Ghent University GILUPI Nanomedizin GlycoZym H. Lee Moffitt Cancer Center & Research Institute, Inc. Hai Kang Life Corporation Limited Health Discovery Corporation Hebrew University of Jerusalem Heragen, Inc. HTG Molecular Diagnostics, Inc. Ikonisys, Inc. IncellDx, Inc. Innovative Health Diagnostics Insight Genetics, Inc. Institut National de la Sante et de la Recherche Medicale IRIS International, Inc. IV Diagnostics, Inc. Iverson Genetic Diagnostics, Inc. Jonakee Cancer Research, Inc. Kalgene Pharmaceuticals Inc. KIYATEC Inc. Leica Biosystems GmbH Louisville Bioscience, Inc. MabCure Inc. Matrix-Bio, Inc. MDNA Life Sciences, Inc. MDxHealth SA MEDITE Cancer Diagnostics, Inc. MedMira Inc. Metabolomic Technologies Inc. MetaStat, Inc. Milagen, Inc. MiRXES Pte Ltd National University of Ireland, Galway Neogenix Oncology, Inc. Novel Bio-spectrum Technologies, Inc. Nuclea Biotechnologies Inc. Nuvera Biosciences, Inc. Olink AB Onconome, Inc. OncoStem Diagnostics Pvt. Ltd OncoVista Innovative Therapies, Inc. Orion Genomics LLC OTraces Inc. Panacea Pharmaceuticals, Inc. PeriRx LLC Power3 Medical Products, Inc. PreMD Inc. Proplex Technologies, Llc Protagen AG Proteome Sciences Plc Proteomika Provista Diagnostics Inc. Qiagen N.V. Quest Diagnostics Incorporated Rna Diagnostics Inc. Roche Diagnostics International Ltd. Rosetta Genomics, Ltd. Savicell Diagnostic Ltd. Selventa Sengenics International Pte Ltd Siamab Therapeutics, Inc. Siemens Healthcare Diagnostics Inc. Sividon Diagnostics GmbH Soricimed Biopharma Inc. Target Discovery, Inc. Taxor Diagnostics, LLC The Johns Hopkins University Todos Medical Trinity College Dublin University of Alberta University of California, San Diego University of Chicago University of Colorado University of Maryland, Baltimore University of Nebraska University of Oxford University of South Florida University of Wisconsin Madison US Biomarkers, Inc. Vermillion, Inc. Viomics Inc. Vitatex Inc. Vitruvian Biomedical, Inc. VolitionRX Ltd. XEPTAGEN SpA Xiamen Zeesan Biotech Co.,Ltd Zetiq Technologies Ltd.
Manager - Marketing
Reportstack Market Research